Trial Profile
Effects of single-dose betrixaban on the QT interval in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2013
Price :
$35
*
At a glance
- Drugs Betrixaban (Primary) ; Moxifloxacin
- Indications Bacterial infections; Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions
- 20 Mar 2013 New trial record
- 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.